Back to Results
First PageMeta Content
RNA interference / Gene expression / Cancer vaccine / Small interfering RNA / Cephalon / Gene therapy / AVI BioPharma / Biology / Genetics / RNA


Contents CHAIRMAN AND THE CEO’S LETTER 1 DIRECTORS’ REPORT
Add to Reading List

Document Date: 2014-11-06 23:24:57


Open Document

File Size: 813,75 KB

Share Result on Facebook

City

San Francisco / Washington / Brisbane / Sydney / The Hague / Barcelona / Perth / New York / Melbourne / London / /

Company

Lodge Partners / Coms plc / Page 8 Benitec Biopharma Ltd / Page 4 Benitec Biopharma Ltd / RNAi / EPO / The Australian Way / Listed Companies / Page 6 Benitec Biopharma Ltd / Pharminox Limited / AMD / Mesoblast Limited / Listed Companies Stemline Therapeutics Inc. / Alchemia Limited / Stemline Therapeutics Inc. / Genable Technologies Ltd / JP Morgan / FASTS / ABC / Leaf Energy Limited / Special Situation Funds / Alexza Pharmaceuticals Inc. / Tissue Therapies Ltd. / Newstar Ventures Ltd. / Special Situations Funds / Epirus Biopharmaceuticals / UOWE Limited / Novogen Limited / Forward Pharma A/S / Listed Companies Ark Therapeutics Group plc / CORPORATE INFORMATION Corporate Structure Benitec Biopharma Limited / Maxim Investment Bank / Brisbane Times / Alnylam / Syngenta International AG / Benitec Biopharma Limited / Education Australia Limited. / Medistem Inc. / RA Capital Management / Ark Therapeutics Group plc / Biomer Technology Limited / Programs Focus Indication Partners / Kellogg / Genetic Technologies Limited / Genera Biosystems Limited / Canada Focus Infectious Disease Indication Partners / Arana Therapeutics Ltd. / Deutsche Bank / Healthlinx Ltd. / Domantis Inc. / Arrowhead / New Yorkbased Maxim Group / Listed Companies ALS Ltd / Sabby Management / Cephalon & GSK / Teva Pharmaceuticals / Calimmune Inc. / Tacere / Page 2 Benitec Biopharma Ltd / Strawman Limited / Cephalon Inc. / Galapagos NV / Calzada Ltd. / BASF SE / Business Review Weekly / Teva Pharmaceutical Industries / Eastman Kodak Company / QANTAS / Progen Pharmaceuticals Ltd. / Polynoma LLC / Dicerna / Principal Activities Benitec Biopharma Limited / Adalta Pty.Ltd / IDP Education Pty Ltd / ScienceMedia Inc. / Anatata Lifesciences Limited. / Bluebird / Xceed Capital Limited. / Cryosite / /

Continent

Europe / /

Country

Brazil / United Kingdom / China / Israel / Mexico / South Africa / Japan / Canada / Australia / Korea / India / New Zealand / Russia / United States / Singapore / Europe / /

Currency

USD / GBP / AUD / /

Event

Reorganization / Earnings Announcement / Second Stock Issuance / M&A / Employment Change / FDA Phase / Diplomatic Relations / Funding / Business Partnership / Company Listing Change / /

Facility

Cancer Associated Pain Stanford University / Company’s US laboratory / Stanford University / Benitec’s US laboratory / Ocular Disease AMD** Stanford University / Wales Hospital / St Vincent’s Hospital / University of London / Company’s pipeline / University of NSW Children’s Cancer Institute / University of California San Diego / Genetic Disease OPMD*** Royal Holloway London University / Wollongong University / Chiplin’s Pharmacy / Northwestern University / University of Washington / Queensland University of Technology Other Current Directorships / University of Nottingham / Cornell University / Non Small Cell* Lung Cancer University of New South Wales / /

IndustryTerm

pharmaceutical industry / suitable commercial pharmaceutical / pharmaceutical industry representatives / gene-silencing technology / healthcare industry / ddRNAi-based gene silencing technology / healthcare/biotech sector / bank / financial services / technology patents / HBV treatment / biotechnology / therapeutic technology / institutional healthcare investors / ddRNAi technology / in-flight magazine / preventative solution / program management / healthcare institutional investors / stage biotechnology / healthcare institutions / gene silencing technology / finance / investment banking / licensed ddRNAi technology / technology lawyers / treatment for Huntington’s disease / print media / pharmaceutical / healthcare / ddRNAi gene silencing technology / important healthcare problem / transformational technology / biopharmaceutical / antibody developer / biotechnology industry / biotechnology funds / leading US healthcare / /

MedicalCondition

resistant lung cancer / HIV / chemotherapy-resistant cancers **Age-Related Macular Degeneration ***Oculopharyngeal Muscular Dystrophy / macular degeneration / ALS / Wet age-related macular degeneration / preclinical in-vivo lung cancer / sarcoma / diseases / HIV/AIDS / inflammatory disease / infection / Huntington’s disease / Hepatitis C / Hepatitis virus / pain / lung cancer / retinitis / Chemotherapy-resistant lung cancer / retinitis pigmentosa / HBV / Hepatitis B / melanoma / incurable diseases / Hepatitis / breast cancer / cancer / HCV / oculopharyngeal muscular dystrophy / macular degeneration treatment / /

MedicalTreatment

chemotherapy / gene therapy / organ transplants / /

OperatingSystem

Isis / Genera / /

Organization

University of Washington / Audit Committee / Cornell University / Genetic Disease OPMD*** Royal Holloway London University / Council of Royal Holloway / St Vincent’s Hospital / Children’s Medical Research Foundation / University of London / New Zealand Society for Cell and Developmental Biology / Duke Clinical Research Unit / Northwestern University / NSW Children’s Cancer Institute / Carnegie Institution / Wollongong University / Queensland University of Technology / Board of Directors of Stemline Therapeutics / Data Safety Monitoring Board / Duke Medical Research Unit / Board of FASTS / Centre for Immunology / University of California San Diego / National Health and Medical Research Council / Board of Directors of TetraLogic Pharmaceuticals / School of Management / Wales Hospital / University of NSW Children / University of New South Wales / Graduate School / US Food and Drug Administration / University of Nottingham / Stanford University / /

Person

Peter Francis / Biomics Biotechnologies / John Chiplin / Prince / Meets Biotech / Peter French / Mel Bridges / Greg West / Maria Kavallaris / David Yeomans / Kevin Buchi / David Suhy / Iain Ross / Carl Stubbings / Craig Lewis / Michael Graham / /

Position

Certified Public Accountant / General / Principal Scientific Officer and Manager / Director Number / Chief Scientific Officer / CEO / Professor / President of the Australia / Managing Director / Melbourne Broker / Qualified Chartered Director / Corporate Vice President / Global Branded Products / board member / Director Benitec Biopharma Ltd Annual Report / CHAIRMAN AND THE CEO / CEO and Managing Director / legal specialist / Non-Executive Chairman / Chief Scientist / leader / BACK COVER Chairman / Non-Executive Director / CHIEF EXECUTIVE OFFICER & MANAGING DIRECTOR / Chief Operating Officer / Chief Financial Officer and Head of Business Development / Vice Chairman / director in the global biotechnology and healthcare industry / Chief Executive Officer / Chartered Accountant / AUDITOR / Chief Executive Officer and Managing Director / Director in August / NON-EXECUTIVE / President and CEO / Director Appointed / founding CEO / Senior Vice President of Research & Development / CEO and public company director / candidate for HIV/AIDS therapeutic / FAICD Non-Executive Director / Prince / COMPANY SECRETARY / Chairman / director / CPA Non-Executive Director / synthetic organic chemist / Senior Vice President of Research and Development / cell and molecular biologist / Chief Medical Adviser / Past President of the Australia / /

Product

cisplatin / GT308 / penicillin / ddRNAi / Cal-1 / US / TT-034 / /

ProgrammingLanguage

php / RC / /

ProvinceOrState

California / New South Wales / /

PublishedMedium

The Geelong Independent / Business Review Weekly / The Australian / Brisbane Times / /

Region

South Wales / South Africa / Northern California / /

SportsLeague

Stanford University / /

Technology

Report Technology / gene-silencing technology / siRNA / licensed ddRNAi technology / chemotherapy / gene silencing technology / ddRNAi-based gene silencing technology / antibodies / biotechnology / gene therapy / ddRNAi technology / ddRNAi gene silencing technology / human genome / Biopharmaceuticals / gene expression / MRI / transformational technology / /

URL

http /

SocialTag